Follow the 메타케어 share price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares are quoted on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 메타케어 has recorded 2 public disclosures. Market capitalisation: €21.5bn. The latest transaction was reported on 7 May 2026 (Sale). Among the most active insiders: 메타랩스. All data is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
MetaCare es una empresa que opera en el sector de la salud y farmacéutico, cotizada en el mercado XKRX. Se enfoca en desarrollar soluciones innovadoras para mejorar los servicios de atención médica.